Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2007
08/22/2007CN101020059A Medicine composition containing docetaxel matter and its prepn process
08/22/2007CN101020058A Application of pure silicon based monodisperse spherical mesoporous molecular sieve in slow release of medicine
08/22/2007CN101020057A Composition for treating solid tumor
08/22/2007CN101020054A Inactivated vaccine for preventing and treating paramyxovirus disease of pigeon and its prepn
08/22/2007CN101020051A Prepn and usage of outer membrane protein subunit vaccine of seawater fish morbid vibrio
08/22/2007CN101020048A Pyemia treating medicine composition
08/22/2007CN101020043A Moistureproof coating method of Xiaojianzhong capsule
08/22/2007CN101020039A Asthma treating hydrogel plaster prepn and its preparing process
08/22/2007CN101020036A Externally applied prepn for treating trauma and its prepn process
08/22/2007CN101020019A Dogskin plaster and its prepn process
08/22/2007CN101020010A Oral liquid for treating common cold heat
08/22/2007CN101020003A Wind evil expelling sea horse plaster and its prepn
08/22/2007CN101019965A Common cold preventing medicine ointment and its prepn
08/22/2007CN101019914A Soft capsule containing lutein and its prepn
08/22/2007CN101019911A Chinese medicine composition possessing antifatigue and immunoregulation functions
08/22/2007CN101019905A Medicine composition containing tribulus fruit furostanol saponin and its application
08/22/2007CN101019902A Slow releasing micro pill prepn of loosestrife extract and its prepn process
08/22/2007CN101019896A Chinese medicine composition for treating hepatitis
08/22/2007CN101019892A Solid pipefish dispersion and its prepn and application
08/22/2007CN101019880A Nanometer liver targeting floxuridine powder for injection and its prepn
08/22/2007CN101019877A Soluble mangiferin clathrate and its prepn
08/22/2007CN101019874A Acarbose medicine composition and its prepn
08/22/2007CN101019872A Nanometer antiviral liposome medicine and its prepn
08/22/2007CN101019871A Emerine salicylate oral liquid and its prepn
08/22/2007CN101019869A Medicine composition of alprostadil and Chuanhuning/Yanhuning liposome and its prepn
08/22/2007CN101019868A Cream for treating alopecia and its prepn
08/22/2007CN101019862A Externally applied prepn containing cnidiadin for treating psoriasis
08/22/2007CN101019859A Water soluble silymarin and its prepn
08/22/2007CN101019858A Medicine composition possessing vasodilation and beta1 receptor blocking effects
08/22/2007CN101019857A Injectable micelle prepn containing garcinolic acid and its prepn process
08/22/2007CN101019852A Freeze dried prepn of medium chain fatty acid liposome and its prepn process
08/22/2007CN101019851A Medium chain fatty acid liposome and its prepn
08/22/2007CN101019850A Externally applied aceclofenac gel prepn and its prepn process
08/22/2007CN101019847A Slow released diacetyl rheinic acid prepn and its prepn process
08/22/2007CN101019838A Linseed oil microcapsule powder and its prepn
08/22/2007CN101019836A Nanometer cytochrome liposome medicine and its prepn
08/22/2007CN101019834A Prepn of 7-ethyl-10-hydroxycamptothecine liposome for injection
08/22/2007CN101019833A Oil-in-oil nonaqueous microemulsion used as medicine carrier and its medicine prepn
08/22/2007CN101019832A Docetaxel fat milk and its freeze dried prepn and their prepn process
08/22/2007CN101019831A Slow releasing anticancer prepn containing vasoinhibitor
08/22/2007CN101019830A Anticancer composition containing phosphoinositide-3-kinase inhibitor and topomerase inhibitor
08/22/2007CN101019829A Slow releasing anticancer prepn containing vasoinhibitor
08/22/2007CN101019828A Anticancer composition containing both phosphoinositide-3-kinase inhibitor and hormone medicine
08/22/2007CN101019827A Anticancer composition containing both phosphoinositide-3-kinase inhibitor and alkylating agent
08/22/2007CN101019825A Process of dissolving 3,5-substituted oxazolidone
08/22/2007CN101019821A Desensitizing anticarious gel and its prepn
08/22/2007CA2578325A1 Megestrol acetate suspension
08/21/2007US7259225 Biodegradable polyphosphazene polymer with sol-gel behavior; a temperature change in aqueous solution in a temperature near a body temperature
08/21/2007US7259186 Salts of fenofibric acid and pharmaceutical formulations thereof
08/21/2007US7259180 Methods and compositions for treatment of macular and retinal disease
08/21/2007US7259153 Drug formulation and delivery using crystalline methylated cyclodextrins
08/21/2007US7259012 Use of oxidized lipoproteins for differentiation of precursor cells into mature dendritic cells
08/21/2007US7258876 applying a mixture of melaleuca alternifolia extract oil, an immunostimulant and an antioxidant; treats most every type of infection caused by pathogenic organisms with little or no side effects.
08/21/2007US7258874 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
08/21/2007US7258872 Chromone enteric release formulation
08/21/2007US7258871 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states
08/21/2007US7258869 Capable of suspending beneficial agents and homogeneously dispensing them over an extended period of time at body temperature and at low flow rates; storage stability; injections; grafting; proteinaceous drugs; antiagglomerants
08/21/2007CA2388610C Oral transmucosal drug dosage using solid solution
08/21/2007CA2332790C Controlled release lipoic acid
08/21/2007CA2320368C Composition comprising theanine
08/21/2007CA2303365C Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
08/21/2007CA2288958C Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
08/21/2007CA2285054C Immobilized activity stabilized lhrh antagonist complexes, method for the production thereof
08/21/2007CA2178517C Neisseria meningitidis capsular polysaccharide conjugates
08/21/2007CA2155947C Methods for in vivo delivery of biologics and compositions useful therefor
08/21/2007CA2139468C Methods for preventing degradation of protein c
08/17/2007CA2569776A1 Low flush niacin formulation
08/16/2007WO2007092964A1 Bladder cancer treatment by using e09 and propylene glycol
08/16/2007WO2007092829A2 Stabilized compositions of proteins having a free thiol moiety
08/16/2007WO2007092161A2 A direct cellular energy delivery system
08/16/2007WO2007091663A1 Carbon nanohorn complex having substance encapsulated therein and method of producing the same
08/16/2007WO2007091661A1 Sugar chain-modified liposome suitable for molecular imaging and utilization and production of the same
08/16/2007WO2007091580A1 Novel vaccine carrier
08/16/2007WO2007091350A1 Solid-phase membrane containing surface-modified albumin or surface-modified serum albumin-metal porphyrin complex and use thereof
08/16/2007WO2007091250A2 Enzyme replacement therapy for treating lysosomal storage diseases
08/16/2007WO2007091061A1 Reducing mitrosamine formation in rubber products
08/16/2007WO2007064719A3 Formulations of quinolinones
08/16/2007WO2007036278A3 Method for stabilising pharmaceutical administration forms that contain micro-organisms
08/16/2007WO2007029003A3 Method of preparing a hydrogel
08/16/2007WO2007016380A3 Cyclitol linker polymer conjugate
08/16/2007WO2006071801A3 Polymer-von willebrand factor-conjugates
08/16/2007WO2006026020A3 Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
08/16/2007WO2002083916A8 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
08/16/2007WO2000000156A3 Methods for modulating immunological responses by targeting antigen to apcs in conjuction with anti-cd40 ligands
08/16/2007US20070191822 Method and apparatus for acne prevention
08/16/2007US20070191597 Preparing therapeutically useful drugs peptides, polypeptides and/or drug delivery systems
08/16/2007US20070191404 Pharmaceutical compositions of pyrimidine-2,4,6-triones
08/16/2007US20070191320 Methods of treatment for female sexual arousal disorder
08/16/2007US20070191297 Methods of treating and monitoring systemic lupus erythematosus in individuals
08/16/2007US20070191286 Injectable composition
08/16/2007US20070191263 Valency platform molecules comprising aminooxy groups
08/16/2007US20070190162 Colloidal suspension of submicronic particles for delivering active principles and method for preparing same
08/16/2007US20070190159 Polyamino acid-based insulin preparation
08/16/2007US20070190158 Pharmaceutical compositions in particulate form
08/16/2007US20070190152 Method for providing an active agent topically to the skin
08/16/2007US20070190136 Process for producing fenofibrate tablets
08/16/2007US20070190134 Compositions containing nicorandil, preparation method and use
08/16/2007US20070190132 Pharmaceutical compositions for oral and topical administration
08/16/2007US20070190128 Suitable for favoring the intracellular delivery of pharmacologically active compounds, facilitating their transmembrane transport, or for promoting their interaction with specific cell membrane sites (receptors)
08/16/2007US20070190116 Solid calcium bolus product with quick dissolution